#Japan #Tokyo #Healthcare Conference #JP Morgan #Astellas Pharma

Astellas Pharma Prepares to Shine at the 44th Annual J.P. Morgan Healthcare Conference

Astellas Pharma Inc., a global leader in life sciences, is set to make a significant impact at the upcoming 44th Annual J.P. Morgan Healthcare Conference, scheduled for January 12-15, 2026, in San Francisco, California. With President and CEO Naoki Okamura at the helm, the company will take this opportunity to highlight its strategic endeavors, showcasing tangible progress in its mission to deliver long-term value for patients, partners, and shareholders.

During the conference, Okamura will share insights into Astellas' key growth drivers and the commitment to disciplined execution that has underpinned their success in a competitive marketplace. Joining him will be Chief Research and Development Officer Tadaaki Taniguchi, who will emphasize Astellas’ focus on advancing transformative breakthroughs in therapeutic areas historically marked by high unmet medical needs. This collaborative presentation aims to reinforce Astellas' position as a changemaker in healthcare innovation.

In Okamura's words, "Our focus is clear; we are working to turn innovative science into meaningful VALUE for patients and drive sustainable growth. The J.P. Morgan Healthcare Conference provides an exceptional opportunity to engage with the global investment and healthcare community and demonstrate how our strategy and execution position Astellas for long-term success."

Presentation Details

• - Event: 44th Annual J.P. Morgan Healthcare Conference
• - Date and Time: January 12, 2026, at 3:00 p.m. PT
• - Location: Westin St. Francis, San Francisco

For those unable to attend, Astellas will provide presentation materials and a live webcast link on its Investor Relations page on the day of the event. Additionally, a link to an on-demand replay will be made available shortly after the presentation concludes, ensuring that key insights are accessible to all stakeholders.

As a distinguished sponsor of the Biotech Showcase occurring concurrently in San Francisco, Astellas is poised to enhance its visibility within the global life sciences community. Moreover, Chief Strategy Officer Adam Pearson will participate in a plenary session focused on partnership trends driving the advancement of emerging technologies and drug development innovation. This underscores Astellas’ commitment to pioneering scientific research and fostering collaborations aimed at improving patient outcomes worldwide.

About Astellas

Astellas is a global life sciences company that focuses on transforming innovative science into VALUE for patients. The organization emphasizes the development of transformative therapies across various disease areas, including oncology, ophthalmology, urology, immunology, and women’s health. Astellas is dedicated to pioneering new healthcare solutions that address significant unmet medical needs through its extensive research and development initiatives. For additional information about the company, visit www.astellas.com.

Cautionary Notes

This announcement includes forward-looking statements regarding Astellas’ strategies and performance. It is essential to note that anticipated results may differ due to various risk factors, including market conditions, regulatory changes, and product launch delays. The information regarding pharmaceutical products mentioned in this press release is not intended as an advertisement or medical advice.